Skip to content

Effect of Elastic Chest Compression on Functional Exercise Capacity and Respiratory Performance in Patients With COPD

Effect of Elastic Chest Compression on Functional Exercise Capacity and Respiratory Performance in Patients With COPD

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06519474
Enrollment
17
Registered
2024-07-25
Start date
2024-07-10
Completion date
2027-05-31
Last updated
2024-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD, Hyperinflation

Keywords

chronic obstructive pulmonary disease, dynamic hyperinflation, elastic chest compression, functional exercise capacity, respiratory performance

Brief summary

The goal of this clinical trial is to investigate the effects of elastic chest compression on functional exercise capacity and respiratory performance of patients with COPD. The main questions it aims to answer are: Is there difference in functional exercise capacity and respiratory performance without or with the use of elastic upper chest compression? Is there difference in functional exercise capacity and respiratory performance between the use of elastic upper chest compression and elastic lower chest compression? Participants will: Be evaluated under three conditions on three different days: without elastic compression, with upper chest compression, and with lower chest compression, with the order of compression application randomly assigned. The functional capacity and respiratory muscle performance of all patients will be evaluated. The days for evaluation will be at least three days apart from each other.

Detailed description

Participants will be evaluated under three conditions: without elastic compression, with upper chest compression, and with lower chest compression, with the order of compression application randomly assigned. A Red Theraband will be used to apply compression to the upper and lower regions of the chest. For a standardized approach to apply compression, the top edge will be aligned with the 3rd intercostal space for the upper chest compression, while the central horizontal part will line up with the xiphoid process of the sternum for the lower chest compression. After exhaling to the EELV, the circumferences of the upper and lower chest regions will be measured, using the 3rd intercostal space as the measurement mark for the upper chest and the xiphoid process of the sternum as the measurement marks for the lower chest. The Thera-Band will be adjusted to 90% of the measured circumferences, ensuring it is securely fastened and standardized resistance is applied consistently to the thoracic regions of interest throughout the study. After chest compression is applied, participants will undergo measurements for functional exercise capacity and respiratory muscle performance.

Interventions

DEVICETheraband chest compression

Chest compression applicated via a Red Theraband over the upper or lower chest region

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* at least 20 years old * has a clinical diagnosis of COPD without infection or acute exacerbation in the previous four weeks * is capable of cooperating with the required tests and measurements of the study

Exclusion criteria

* has any clinical diagnosis that could affect test outcomes (e.g., neuromyopathy) * has experienced unstable angina or an acute myocardial infarction within the last month * has adjusted COPD related medication within the last month * a Mini-Mental State Examination (MMSE) score below 24

Design outcomes

Primary

MeasureTime frameDescription
Respiratory muscle performanceup to 3 weeksMaximum inspiratory (MIP) and expiratory pressures (MEP) in mmH2O
Functional exercise capacityup to 3 weeks6 minute walk test measured in meters
Respiratory flow performanceup to 3 weekspeak inspiratory (PIFR) and expiratory flows (PEFR) in liter per minute

Countries

Taiwan

Contacts

Primary ContactYi Chun Chen
G00997@hch.gov.tw+886-5326151
Backup ContactYi Chun Chen
jenchein@gmail.com+886-961320509

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026